Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancer

Summary

Multicenter open label, uncontrolled study that enrolled men with metastatic castrate resistant prostate cancer previously treated with sipuleucel-T in the androgen dependent setting in the Dendreon P-11 study. The study was divided into Active and Long Term Follow-up (LTFU) Phases.

Timeline

Start

2011-12

Primary completion

2015-04

Completion

2015-04

Drugs

Indications